[go: up one dir, main page]

SV1997000090A - Composiciones farmaceuticas. - Google Patents

Composiciones farmaceuticas.

Info

Publication number
SV1997000090A
SV1997000090A SV1997000090A SV1997000090A SV1997000090A SV 1997000090 A SV1997000090 A SV 1997000090A SV 1997000090 A SV1997000090 A SV 1997000090A SV 1997000090 A SV1997000090 A SV 1997000090A SV 1997000090 A SV1997000090 A SV 1997000090A
Authority
SV
El Salvador
Prior art keywords
pharmaceutical compositions
lubricant
lucan
lamivudine
zidovudine
Prior art date
Application number
SV1997000090A
Other languages
English (en)
Inventor
Gary Wayne Goodson
Wood Allen Wayne
Katherine Jeannette Ford
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SV1997000090A publication Critical patent/SV1997000090A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

SE DESCRIBE UNA COMPOSICION FARMACEUTICAMENTE Y UN METODO PARA INHIBIR EL VIRUS DE LA INMUNODEFICIENCIA HUMANA (VIH) EL CUAL COMPRENDE ADMINISTRAR A UN PACIENTE INFECTADO POR VIH UNA COMBINACION HOMOGENEA DE LAMIVUDINA, ZIDOVUDINA Y UN LUBRICANTE FARMACEUTICO EN UNA CANTIDAD QUE LOGRA EFICACIA ANTIVIRAL
SV1997000090A 1996-10-31 1997-10-28 Composiciones farmaceuticas. SV1997000090A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9622681.6A GB9622681D0 (en) 1996-10-31 1996-10-31 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SV1997000090A true SV1997000090A (es) 1998-10-07

Family

ID=10802224

Family Applications (1)

Application Number Title Priority Date Filing Date
SV1997000090A SV1997000090A (es) 1996-10-31 1997-10-28 Composiciones farmaceuticas.

Country Status (43)

Country Link
EP (1) EP0941100B1 (es)
JP (1) JP2001502718A (es)
KR (1) KR100551652B1 (es)
AP (1) AP1067A (es)
AR (1) AR009135A1 (es)
AT (1) ATE241364T1 (es)
AU (1) AU736607B2 (es)
BG (1) BG64541B1 (es)
BR (1) BR9712614A (es)
CA (1) CA2270174A1 (es)
CO (1) CO4930269A1 (es)
CY (1) CY2485B1 (es)
CZ (1) CZ296080B6 (es)
DE (1) DE69722433T2 (es)
DK (1) DK0941100T3 (es)
EA (1) EA002437B1 (es)
EE (1) EE03806B1 (es)
ES (1) ES2200204T3 (es)
GB (1) GB9622681D0 (es)
GE (1) GEP20022735B (es)
GT (1) GT199700116A (es)
HR (1) HRP970569B1 (es)
HU (1) HU224969B1 (es)
ID (1) ID18698A (es)
IL (1) IL129422A0 (es)
IS (1) IS5024A (es)
MY (1) MY119513A (es)
NO (1) NO317163B1 (es)
NZ (1) NZ335153A (es)
OA (1) OA11038A (es)
PA (1) PA8441101A1 (es)
PE (1) PE10099A1 (es)
PL (1) PL190349B1 (es)
PT (1) PT941100E (es)
SI (1) SI0941100T1 (es)
SK (1) SK284286B6 (es)
SV (1) SV1997000090A (es)
TR (1) TR199900950T2 (es)
UA (1) UA64725C2 (es)
UY (1) UY24766A1 (es)
WO (1) WO1998018477A2 (es)
YU (1) YU19999A (es)
ZA (1) ZA979726B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
DE60219965T2 (de) * 2002-04-23 2008-01-17 Lupin Ltd., Mumbai Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine
ATE361059T1 (de) * 2002-11-08 2007-05-15 Glaxo Group Ltd Antivirale zusammensetzungen
AU2004206821C1 (en) 2003-01-14 2009-10-01 Gilead Sciences, Inc. Compositions and methods for combination antiviral therapy
AR045841A1 (es) * 2004-09-28 2005-11-16 Richmond Sa Com Ind Y Financie Una composicion farmaceutica solida que comprende al tiazolil metil ester del acido [5s-(5r*, 8r*, 10r*,11r*)] -10- hidroxi-2- metil-5-(1-metiletil)-1-[2-(1-metiletil)-4-tiazolil]-3,6-dioxo-8,11-bis(fenilmetil)-2,4,7,12- tetraazatridecan-13-oico y un procedimiento para prepararla.
CN114010776A (zh) 2010-06-09 2022-02-08 疫苗技术股份有限公司 用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫
EP2822560A1 (en) 2012-03-05 2015-01-14 Cipla Limited Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine
EP2958563A2 (en) * 2013-02-20 2015-12-30 AbbVie Inc. Tablet dosage form comprising ritonavir and lopinavir

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
GB9110624D0 (en) * 1991-05-16 1991-07-03 Glaxo Group Ltd Combinations
AU1787492A (en) * 1991-05-16 1992-12-30 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
PT941100E (pt) 2003-10-31
CY2485B1 (en) 2005-06-03
UY24766A1 (es) 2000-12-29
JP2001502718A (ja) 2001-02-27
PL190349B1 (pl) 2005-11-30
PA8441101A1 (es) 2000-05-24
ATE241364T1 (de) 2003-06-15
GT199700116A (es) 1999-04-22
ID18698A (id) 1998-04-30
PE10099A1 (es) 1999-03-02
HRP970569A2 (en) 1998-08-31
EA002437B1 (ru) 2002-04-25
AU5314298A (en) 1998-05-22
HUP0000344A2 (hu) 2001-05-28
GB9622681D0 (en) 1997-01-08
EP0941100B1 (en) 2003-05-28
BR9712614A (pt) 1999-10-26
WO1998018477A2 (en) 1998-05-07
NO992091L (no) 1999-06-29
HRP970569B1 (en) 2004-10-31
YU19999A (sh) 2000-10-30
ZA979726B (en) 1999-04-29
CA2270174A1 (en) 1998-05-07
MY119513A (en) 2005-06-30
GEP20022735B (en) 2002-07-25
WO1998018477A3 (en) 1998-06-18
NO317163B1 (no) 2004-08-30
HU224969B1 (en) 2006-04-28
BG64541B1 (bg) 2005-07-29
DK0941100T3 (da) 2003-09-01
OA11038A (en) 2002-02-06
TR199900950T2 (xx) 1999-07-21
AP9901519A0 (en) 1999-06-30
NZ335153A (en) 2001-04-27
UA64725C2 (uk) 2004-03-15
DE69722433D1 (de) 2003-07-03
AP1067A (en) 2002-05-01
BG103435A (en) 2000-04-28
KR100551652B1 (ko) 2006-02-13
CZ155799A3 (cs) 1999-10-13
SK57599A3 (en) 2000-06-12
IL129422A0 (en) 2000-02-17
NO992091D0 (no) 1999-04-29
IS5024A (is) 1999-04-09
EP0941100A2 (en) 1999-09-15
SI0941100T1 (en) 2003-12-31
DE69722433T2 (de) 2004-04-08
ES2200204T3 (es) 2004-03-01
HUP0000344A3 (en) 2002-04-29
HK1020880A1 (en) 2000-05-26
CO4930269A1 (es) 2000-06-27
EE03806B1 (et) 2002-08-15
SK284286B6 (sk) 2005-01-03
PL333143A1 (en) 1999-11-22
KR20000052893A (ko) 2000-08-25
CZ296080B6 (cs) 2006-01-11
AR009135A1 (es) 2000-03-08
EE9900175A (et) 1999-12-15
AU736607B2 (en) 2001-08-02
EA199900345A1 (ru) 2000-02-28

Similar Documents

Publication Publication Date Title
DE60104206D1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
ES2179193T3 (es) Combinaciones sinergicas de zidovudina, 1592u89 y 3tc.
AR022008A1 (es) Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento
YU7296A (sh) Farmaceutska kompozicija koja sadrži kombinaciju jedne protivvirusne supstance i jednog protivzapaljenskog glukokortikoida
AR013269A1 (es) Producto que contiene por lo menos un rna de doble filamento combinado con por lo menos un agente anti-viral, para la utilizacion terapeutica en eltratamiento de una enfermedad viral, en especial de la hepatitis viral
ES2185760T3 (es) Composicion farmaceutica para el tratamiento del herpes.
MX9204454A (es) Derivados de tiourea para inhibir la replicacion del virus de inmunodeficiencia humana y formulado farmaceutico que los contiene.
PA8588501A1 (es) Derivados antivirales de nucleósidos
ES2178037T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que los contienen.
DE69811062D1 (de) Polyaromatische antivirale zusammensetzungen
SV1997000090A (es) Composiciones farmaceuticas.
MX9203972A (es) Compuestos inhibidores de la proteasa codificada por el virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulado farmaceutico que los contiene.
ES2061688T3 (es) Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
EA200000997A1 (ru) Гомогенные фармацевтические композиции, содержащие абакавир, ламивудин и зидовудин
ES2182255T3 (es) Agente de blanqueo fluorescente.
BR9916575A (pt) Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa
BR0008302A (pt) Uso de um derivado de benzaldeìdo, derivado de benzaldeìdo, composição farmacêutica, e, processo para a fabricação da mesma
ES2132556T3 (es) Nuevo derivado de benzo-tiadiazina, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
ES2103577T3 (es) Compuestos antiviricos de naftoquinona, composiciones que los contienen y utilizaciones de estos compuestos.
MX9303709A (es) Nucleosidos de purina substituidos e intermediarios de los mismos, que tienen actividad anti-viral y anti-cancerigena y composicion farmaceutica que los contiene.
AR002247A1 (es) Eleuterobina y analogos de la misma y composiciones que las comprenden.
AR002957A1 (es) Una combinacion de compuestos utiles, su uso para preparar un medicamento, y una composicion y combinacion farmaceutica que los contienen.
EA200100711A1 (ru) Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция
AR023661A1 (es) Combinaciones antivirales
MX9700044A (es) Combinacion triple anti-virus de inmunodeficiencia humana.

Legal Events

Date Code Title Description
FD Lapse